Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
The regulatory function is vital in making safe and effective healthcare products available worldwide. Individuals who ensure regulatory compliance and prepare submissions, as well as those whose main job function is clinical affairs or quality assurance are all considered regulatory professionals.
Resources, news and special offers to support you and your professional development during this difficult time.
One of our most valuable contributions to the profession is the Regulatory Code of Ethics. The Code of Ethics provides regulatory professionals with core values that hold them to the highest standards of professional conduct.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Like all professions, regulatory is based on a shared set of competencies. The Regulatory Competency Framework describes the essential elements of what is required of regulatory professionals at four major career and professional levels.
Download your copy of the new events calendar and see all the online workshops, conferences, RAC exams and European online workshops RAPS has planned for 2021 at a glance.
An invaluable resource for any professional engaged in designing, composing, compiling, or commenting on regulatory documentation
From self-assessments to help you identify your strengths and areas to focus on to reference books and online courses that will help you fill in the gaps in your regulatory knowledge, RAPS has the resources to help you prepare for the RAC exam.
The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move across top level links and expand / close menus in sub levels. Up and Down arrows will open main level menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab will move on to the next part of the site rather than go through menu items.
Posted 20 June 2012 | By Alexander Gaffney, RAC
A new report put out by the US Food and Drug Administration's Office of Science and Engineering Laboratories (OSEL), part of the Center for Devices and Radiological Health (CDRH), provides an overview of the Office's activities during 2011 and insight into what it considers to be its priorities.
OSEL is primarily engaged in two core activities, the report explains. First, the office manages research activities with the aim of "providing a scientifically sound basis for responding to current needs and anticipating future regulatory challenges." Second, OSEL provides other CDRH offices with technical consultations to support the evaluation and postmarketing surveillance of medical device products.
The two activities are apparently keeping the office busy. In 2011, OSEL provided CDRH with 1,780 premarket device consultations and 142 postmarketing consultations. These scientific consultations were used in a wide range of activities, including evaluations, compliance actions, scientific collaborations, responding to inquiries and guidance document feedback.
Not content to let the numbers tell the story, the OSEL report provides a huge range of highlighted vignettes of staff accomplishments. Among the office's scientific accomplishments include the development of an implantable brain computer interface platform, a nanoparticle-based test method to ensure the accuracy of optical coherence tomography data, and the launch of a joint program with the Department of Homeland Security (DHS) to assess the risks of patients to electromagnetic interference on airplanes.
Another interesting observation from OSEL involves the postmarketing failure of medical devices. "As many as one-third of medical device failures causing patient harm reported to the FDA appear to be failures of medical device use rather than failure of the device itself," the office observed. To assist with the development of device safety, OSEL formed the Functional Performance and Device Use Laboratory within its Division of Physics, which serves to test the usability and use of medical devices.
Still another oft-encountered problem deals with the increasing use of unvalidated computational safety and efficacy models to support premarket applications. OSEL said its Division of Physics has teamed up with the Institute of Electrical and Electronics Engineers and the International Electrotechnical Committee to standardize validation procedures for computational codes using specific methods.
Read more:
OSEL 2011 Activities Report
Tags: OSEL, Report, Latest News, medical device
Regulatory Focus newsletters
All the biggest regulatory news and happenings.